This inventor holds 28 USPTO granted patents and 7 published patent applications and 3 EPO patents, primarily in Chemical Engineering. Top assignees: E.i. Dupont De Nemours and Company, Invista North America S.a.r.l., Cytokinetics, Inc.. Active years: 2001-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oak Park, CA (US) (2007 - 2012)
- Wilmington, DE (US) (2001 - 2024)
Company Filing History:
16 out of 16,339 
6 out of 395 
4 out of 261 
Years Active: 2001-2026
Areas of Expertise:
Title: Innovations and Achievements of Alan Martin Allgeier
Introduction
Alan Martin Allgeier is a notable inventor based in Wilmington, DE, USA, with a remarkable portfolio of 27 patents to his name. His work primarily focuses on pharmaceutical formulations and innovative methods that contribute significantly to the field of drug development.
Latest Patents
Among his latest contributions are patents centered around the compound omecamtiv mecarbil. These patents include "Salt of omecamtiv mecarbil and process for preparing salt," which provides valuable dihydrochloride salt forms, compositions, and pharmaceutical formulations, alongside methods for their preparation and use. This work showcases his dedication to advancing medical science through innovative pharmaceutical solutions.
Career Highlights
Throughout his career, Alan has been affiliated with prominent companies such as E.I. du Pont de Nemours and Company and Invista North America S.a.r.l. His roles within these organizations have allowed him to leverage his inventive skills and contribute to groundbreaking research and development in his field.
Collaborations
Alan's innovative journey has also been enriched through collaborations with peers such as Sourav Kumar Sengupta and Wathudura Indika Namal De Silva. These partnerships have facilitated knowledge exchange and enhanced the quality of the innovations he has been part of, leading to successful patent applications and contributions to research.
Conclusion
Alan Martin Allgeier stands out as a significant figure in the world of inventions and patents. His extensive experience, combined with his commitment to advancing pharmaceutical sciences, underscores the impact of collaborative innovation in addressing medical challenges. With his continuous contributions, he remains an influential inventor paving the way for future advancements in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile